nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A8—Pravastatin—atherosclerosis	0.279	0.454	CbGbCtD
Famotidine—CYP2C19—Rosuvastatin—atherosclerosis	0.118	0.192	CbGbCtD
Famotidine—CYP2C19—Simvastatin—atherosclerosis	0.11	0.179	CbGbCtD
Famotidine—CYP2C19—Lovastatin—atherosclerosis	0.107	0.175	CbGbCtD
Famotidine—Erectile dysfunction—Niacin—atherosclerosis	0.00122	0.00366	CcSEcCtD
Famotidine—Dysuria—Pravastatin—atherosclerosis	0.00122	0.00366	CcSEcCtD
Famotidine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00122	0.00363	CcSEcCtD
Famotidine—Hepatitis—Ezetimibe—atherosclerosis	0.00121	0.00363	CcSEcCtD
Famotidine—Sinusitis—Simvastatin—atherosclerosis	0.00121	0.00362	CcSEcCtD
Famotidine—Pharyngitis—Ezetimibe—atherosclerosis	0.0012	0.0036	CcSEcCtD
Famotidine—Erectile dysfunction—Pravastatin—atherosclerosis	0.0012	0.0036	CcSEcCtD
Famotidine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00119	0.00357	CcSEcCtD
Famotidine—Erythema multiforme—Lovastatin—atherosclerosis	0.00117	0.0035	CcSEcCtD
Famotidine—Depression—Pravastatin—atherosclerosis	0.00116	0.00348	CcSEcCtD
Famotidine—Angioedema—Rosuvastatin—atherosclerosis	0.00116	0.00347	CcSEcCtD
Famotidine—Hepatitis—Simvastatin—atherosclerosis	0.00116	0.00346	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00116	0.00346	CcSEcCtD
Famotidine—Jaundice—Niacin—atherosclerosis	0.00115	0.00345	CcSEcCtD
Famotidine—Flushing—Lovastatin—atherosclerosis	0.00115	0.00344	CcSEcCtD
Famotidine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00115	0.00343	CcSEcCtD
Famotidine—Jaundice—Pravastatin—atherosclerosis	0.00114	0.0034	CcSEcCtD
Famotidine—Flushing—Ezetimibe—atherosclerosis	0.00113	0.00337	CcSEcCtD
Famotidine—Cough—Rosuvastatin—atherosclerosis	0.00111	0.00332	CcSEcCtD
Famotidine—Erythema multiforme—Simvastatin—atherosclerosis	0.00109	0.00327	CcSEcCtD
Famotidine—Sinusitis—Pravastatin—atherosclerosis	0.00109	0.00327	CcSEcCtD
Famotidine—Alopecia—Lovastatin—atherosclerosis	0.00109	0.00327	CcSEcCtD
Famotidine—Myalgia—Rosuvastatin—atherosclerosis	0.00108	0.00324	CcSEcCtD
Famotidine—Arthralgia—Rosuvastatin—atherosclerosis	0.00108	0.00324	CcSEcCtD
Famotidine—Flushing—Simvastatin—atherosclerosis	0.00107	0.00321	CcSEcCtD
Famotidine—Alopecia—Ezetimibe—atherosclerosis	0.00107	0.00321	CcSEcCtD
Famotidine—Mental disorder—Ezetimibe—atherosclerosis	0.00106	0.00318	CcSEcCtD
Famotidine—Hepatitis—Niacin—atherosclerosis	0.00106	0.00318	CcSEcCtD
Famotidine—Dysgeusia—Lovastatin—atherosclerosis	0.00105	0.00316	CcSEcCtD
Famotidine—Hepatitis—Pravastatin—atherosclerosis	0.00105	0.00313	CcSEcCtD
Famotidine—Confusional state—Rosuvastatin—atherosclerosis	0.00105	0.00313	CcSEcCtD
Famotidine—Back pain—Lovastatin—atherosclerosis	0.00104	0.00312	CcSEcCtD
Famotidine—Pharyngitis—Pravastatin—atherosclerosis	0.00104	0.00311	CcSEcCtD
Famotidine—Muscle spasms—Lovastatin—atherosclerosis	0.00104	0.0031	CcSEcCtD
Famotidine—Infection—Rosuvastatin—atherosclerosis	0.00103	0.00308	CcSEcCtD
Famotidine—Alopecia—Simvastatin—atherosclerosis	0.00102	0.00306	CcSEcCtD
Famotidine—Back pain—Ezetimibe—atherosclerosis	0.00102	0.00306	CcSEcCtD
Famotidine—Muscle spasms—Ezetimibe—atherosclerosis	0.00102	0.00304	CcSEcCtD
Famotidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00102	0.00304	CcSEcCtD
Famotidine—Mental disorder—Simvastatin—atherosclerosis	0.00101	0.00303	CcSEcCtD
Famotidine—Tinnitus—Niacin—atherosclerosis	0.000991	0.00296	CcSEcCtD
Famotidine—Erythema multiforme—Pravastatin—atherosclerosis	0.000989	0.00296	CcSEcCtD
Famotidine—Dysgeusia—Simvastatin—atherosclerosis	0.000987	0.00295	CcSEcCtD
Famotidine—Flushing—Niacin—atherosclerosis	0.000986	0.00295	CcSEcCtD
Famotidine—Angioedema—Lovastatin—atherosclerosis	0.000984	0.00294	CcSEcCtD
Famotidine—Anaemia—Ezetimibe—atherosclerosis	0.000977	0.00292	CcSEcCtD
Famotidine—Tinnitus—Pravastatin—atherosclerosis	0.000976	0.00292	CcSEcCtD
Famotidine—Flushing—Pravastatin—atherosclerosis	0.000971	0.00291	CcSEcCtD
Famotidine—Muscle spasms—Simvastatin—atherosclerosis	0.000969	0.0029	CcSEcCtD
Famotidine—Angioedema—Ezetimibe—atherosclerosis	0.000965	0.00289	CcSEcCtD
Famotidine—Leukopenia—Lovastatin—atherosclerosis	0.000964	0.00288	CcSEcCtD
Famotidine—Arrhythmia—Niacin—atherosclerosis	0.000949	0.00284	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000945	0.00283	CcSEcCtD
Famotidine—Alopecia—Niacin—atherosclerosis	0.000939	0.00281	CcSEcCtD
Famotidine—Insomnia—Rosuvastatin—atherosclerosis	0.000938	0.00281	CcSEcCtD
Famotidine—Arrhythmia—Pravastatin—atherosclerosis	0.000935	0.0028	CcSEcCtD
Famotidine—Palpitations—Ezetimibe—atherosclerosis	0.000934	0.00279	CcSEcCtD
Famotidine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000932	0.00279	CcSEcCtD
Famotidine—Anaemia—Simvastatin—atherosclerosis	0.000931	0.00279	CcSEcCtD
Famotidine—Alopecia—Pravastatin—atherosclerosis	0.000925	0.00277	CcSEcCtD
Famotidine—Cough—Ezetimibe—atherosclerosis	0.000922	0.00276	CcSEcCtD
Famotidine—Angioedema—Simvastatin—atherosclerosis	0.000921	0.00275	CcSEcCtD
Famotidine—Arthralgia—Lovastatin—atherosclerosis	0.000917	0.00274	CcSEcCtD
Famotidine—Chest pain—Lovastatin—atherosclerosis	0.000917	0.00274	CcSEcCtD
Famotidine—Myalgia—Lovastatin—atherosclerosis	0.000917	0.00274	CcSEcCtD
Famotidine—Anxiety—Lovastatin—atherosclerosis	0.000914	0.00273	CcSEcCtD
Famotidine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000913	0.00273	CcSEcCtD
Famotidine—Leukopenia—Simvastatin—atherosclerosis	0.000902	0.0027	CcSEcCtD
Famotidine—Arthralgia—Ezetimibe—atherosclerosis	0.0009	0.00269	CcSEcCtD
Famotidine—Chest pain—Ezetimibe—atherosclerosis	0.0009	0.00269	CcSEcCtD
Famotidine—Myalgia—Ezetimibe—atherosclerosis	0.0009	0.00269	CcSEcCtD
Famotidine—Dry mouth—Lovastatin—atherosclerosis	0.000897	0.00268	CcSEcCtD
Famotidine—Dysgeusia—Pravastatin—atherosclerosis	0.000892	0.00267	CcSEcCtD
Famotidine—Muscle spasms—Niacin—atherosclerosis	0.00089	0.00266	CcSEcCtD
Famotidine—Pain—Rosuvastatin—atherosclerosis	0.000887	0.00265	CcSEcCtD
Famotidine—Constipation—Rosuvastatin—atherosclerosis	0.000887	0.00265	CcSEcCtD
Famotidine—Confusional state—Lovastatin—atherosclerosis	0.000886	0.00265	CcSEcCtD
Famotidine—Dry mouth—Ezetimibe—atherosclerosis	0.00088	0.00263	CcSEcCtD
Famotidine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000879	0.00263	CcSEcCtD
Famotidine—Muscle spasms—Pravastatin—atherosclerosis	0.000876	0.00262	CcSEcCtD
Famotidine—Infection—Lovastatin—atherosclerosis	0.000873	0.00261	CcSEcCtD
Famotidine—Confusional state—Ezetimibe—atherosclerosis	0.00087	0.0026	CcSEcCtD
Famotidine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000862	0.00258	CcSEcCtD
Famotidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000861	0.00258	CcSEcCtD
Famotidine—Chest pain—Simvastatin—atherosclerosis	0.000858	0.00257	CcSEcCtD
Famotidine—Arthralgia—Simvastatin—atherosclerosis	0.000858	0.00257	CcSEcCtD
Famotidine—Myalgia—Simvastatin—atherosclerosis	0.000858	0.00257	CcSEcCtD
Famotidine—Infection—Ezetimibe—atherosclerosis	0.000857	0.00256	CcSEcCtD
Famotidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000855	0.00256	CcSEcCtD
Famotidine—Anxiety—Simvastatin—atherosclerosis	0.000855	0.00256	CcSEcCtD
Famotidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000848	0.00254	CcSEcCtD
Famotidine—Angioedema—Niacin—atherosclerosis	0.000845	0.00253	CcSEcCtD
Famotidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000844	0.00253	CcSEcCtD
Famotidine—Anaemia—Pravastatin—atherosclerosis	0.000842	0.00252	CcSEcCtD
Famotidine—Anorexia—Lovastatin—atherosclerosis	0.000838	0.00251	CcSEcCtD
Famotidine—Angioedema—Pravastatin—atherosclerosis	0.000832	0.00249	CcSEcCtD
Famotidine—Syncope—Niacin—atherosclerosis	0.00083	0.00248	CcSEcCtD
Famotidine—Confusional state—Simvastatin—atherosclerosis	0.000829	0.00248	CcSEcCtD
Famotidine—Leukopenia—Niacin—atherosclerosis	0.000828	0.00248	CcSEcCtD
Famotidine—Urticaria—Rosuvastatin—atherosclerosis	0.000824	0.00247	CcSEcCtD
Famotidine—Oedema—Simvastatin—atherosclerosis	0.000822	0.00246	CcSEcCtD
Famotidine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000822	0.00246	CcSEcCtD
Famotidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00082	0.00245	CcSEcCtD
Famotidine—Palpitations—Niacin—atherosclerosis	0.000818	0.00245	CcSEcCtD
Famotidine—Infection—Simvastatin—atherosclerosis	0.000817	0.00244	CcSEcCtD
Famotidine—Leukopenia—Pravastatin—atherosclerosis	0.000815	0.00244	CcSEcCtD
Famotidine—Loss of consciousness—Niacin—atherosclerosis	0.000813	0.00243	CcSEcCtD
Famotidine—Cough—Niacin—atherosclerosis	0.000807	0.00242	CcSEcCtD
Famotidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000805	0.00241	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000801	0.0024	CcSEcCtD
Famotidine—Insomnia—Lovastatin—atherosclerosis	0.000795	0.00238	CcSEcCtD
Famotidine—Cough—Pravastatin—atherosclerosis	0.000795	0.00238	CcSEcCtD
Famotidine—Paraesthesia—Lovastatin—atherosclerosis	0.000789	0.00236	CcSEcCtD
Famotidine—Arthralgia—Niacin—atherosclerosis	0.000788	0.00236	CcSEcCtD
Famotidine—Myalgia—Niacin—atherosclerosis	0.000788	0.00236	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000786	0.00235	CcSEcCtD
Famotidine—Anorexia—Simvastatin—atherosclerosis	0.000784	0.00234	CcSEcCtD
Famotidine—Insomnia—Ezetimibe—atherosclerosis	0.00078	0.00233	CcSEcCtD
Famotidine—Myalgia—Pravastatin—atherosclerosis	0.000776	0.00232	CcSEcCtD
Famotidine—Arthralgia—Pravastatin—atherosclerosis	0.000776	0.00232	CcSEcCtD
Famotidine—Chest pain—Pravastatin—atherosclerosis	0.000776	0.00232	CcSEcCtD
Famotidine—Paraesthesia—Ezetimibe—atherosclerosis	0.000774	0.00232	CcSEcCtD
Famotidine—Dyspepsia—Lovastatin—atherosclerosis	0.000774	0.00232	CcSEcCtD
Famotidine—Anxiety—Pravastatin—atherosclerosis	0.000773	0.00231	CcSEcCtD
Famotidine—Dry mouth—Niacin—atherosclerosis	0.00077	0.0023	CcSEcCtD
Famotidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000764	0.00229	CcSEcCtD
Famotidine—Decreased appetite—Lovastatin—atherosclerosis	0.000764	0.00229	CcSEcCtD
Famotidine—Dyspepsia—Ezetimibe—atherosclerosis	0.000759	0.00227	CcSEcCtD
Famotidine—Fatigue—Lovastatin—atherosclerosis	0.000758	0.00227	CcSEcCtD
Famotidine—Anaphylactic shock—Niacin—atherosclerosis	0.000755	0.00226	CcSEcCtD
Famotidine—Oedema—Niacin—atherosclerosis	0.000755	0.00226	CcSEcCtD
Famotidine—Pain—Lovastatin—atherosclerosis	0.000752	0.00225	CcSEcCtD
Famotidine—Constipation—Lovastatin—atherosclerosis	0.000752	0.00225	CcSEcCtD
Famotidine—Confusional state—Pravastatin—atherosclerosis	0.00075	0.00224	CcSEcCtD
Famotidine—Decreased appetite—Ezetimibe—atherosclerosis	0.00075	0.00224	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000749	0.00224	CcSEcCtD
Famotidine—Asthenia—Rosuvastatin—atherosclerosis	0.000744	0.00223	CcSEcCtD
Famotidine—Insomnia—Simvastatin—atherosclerosis	0.000744	0.00223	CcSEcCtD
Famotidine—Oedema—Pravastatin—atherosclerosis	0.000743	0.00222	CcSEcCtD
Famotidine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000743	0.00222	CcSEcCtD
Famotidine—Fatigue—Ezetimibe—atherosclerosis	0.000743	0.00222	CcSEcCtD
Famotidine—Shock—Niacin—atherosclerosis	0.000743	0.00222	CcSEcCtD
Famotidine—Infection—Pravastatin—atherosclerosis	0.000739	0.00221	CcSEcCtD
Famotidine—Paraesthesia—Simvastatin—atherosclerosis	0.000738	0.00221	CcSEcCtD
Famotidine—Constipation—Ezetimibe—atherosclerosis	0.000737	0.00221	CcSEcCtD
Famotidine—Pain—Ezetimibe—atherosclerosis	0.000737	0.00221	CcSEcCtD
Famotidine—Pruritus—Rosuvastatin—atherosclerosis	0.000734	0.0022	CcSEcCtD
Famotidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000728	0.00218	CcSEcCtD
Famotidine—Feeling abnormal—Lovastatin—atherosclerosis	0.000725	0.00217	CcSEcCtD
Famotidine—Dyspepsia—Simvastatin—atherosclerosis	0.000724	0.00217	CcSEcCtD
Famotidine—Anorexia—Niacin—atherosclerosis	0.00072	0.00215	CcSEcCtD
Famotidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000719	0.00215	CcSEcCtD
Famotidine—Decreased appetite—Simvastatin—atherosclerosis	0.000715	0.00214	CcSEcCtD
Famotidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000711	0.00213	CcSEcCtD
Famotidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00071	0.00212	CcSEcCtD
Famotidine—Fatigue—Simvastatin—atherosclerosis	0.000709	0.00212	CcSEcCtD
Famotidine—Anorexia—Pravastatin—atherosclerosis	0.000709	0.00212	CcSEcCtD
Famotidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000705	0.00211	CcSEcCtD
Famotidine—Pain—Simvastatin—atherosclerosis	0.000703	0.0021	CcSEcCtD
Famotidine—Constipation—Simvastatin—atherosclerosis	0.000703	0.0021	CcSEcCtD
Famotidine—Urticaria—Lovastatin—atherosclerosis	0.000698	0.00209	CcSEcCtD
Famotidine—Abdominal pain—Lovastatin—atherosclerosis	0.000695	0.00208	CcSEcCtD
Famotidine—Body temperature increased—Lovastatin—atherosclerosis	0.000695	0.00208	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000688	0.00206	CcSEcCtD
Famotidine—Dizziness—Rosuvastatin—atherosclerosis	0.000686	0.00205	CcSEcCtD
Famotidine—Urticaria—Ezetimibe—atherosclerosis	0.000685	0.00205	CcSEcCtD
Famotidine—Insomnia—Niacin—atherosclerosis	0.000683	0.00204	CcSEcCtD
Famotidine—Abdominal pain—Ezetimibe—atherosclerosis	0.000682	0.00204	CcSEcCtD
Famotidine—Body temperature increased—Ezetimibe—atherosclerosis	0.000682	0.00204	CcSEcCtD
Famotidine—Paraesthesia—Niacin—atherosclerosis	0.000678	0.00203	CcSEcCtD
Famotidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000678	0.00203	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000677	0.00203	CcSEcCtD
Famotidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000672	0.00201	CcSEcCtD
Famotidine—Insomnia—Pravastatin—atherosclerosis	0.000672	0.00201	CcSEcCtD
Famotidine—Somnolence—Niacin—atherosclerosis	0.000671	0.00201	CcSEcCtD
Famotidine—Paraesthesia—Pravastatin—atherosclerosis	0.000668	0.002	CcSEcCtD
Famotidine—Dyspepsia—Niacin—atherosclerosis	0.000665	0.00199	CcSEcCtD
Famotidine—Decreased appetite—Niacin—atherosclerosis	0.000656	0.00196	CcSEcCtD
Famotidine—Dyspepsia—Pravastatin—atherosclerosis	0.000654	0.00196	CcSEcCtD
Famotidine—Rash—Rosuvastatin—atherosclerosis	0.000654	0.00196	CcSEcCtD
Famotidine—Dermatitis—Rosuvastatin—atherosclerosis	0.000654	0.00195	CcSEcCtD
Famotidine—Urticaria—Simvastatin—atherosclerosis	0.000653	0.00195	CcSEcCtD
Famotidine—Body temperature increased—Simvastatin—atherosclerosis	0.00065	0.00194	CcSEcCtD
Famotidine—Abdominal pain—Simvastatin—atherosclerosis	0.00065	0.00194	CcSEcCtD
Famotidine—Headache—Rosuvastatin—atherosclerosis	0.00065	0.00194	CcSEcCtD
Famotidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000648	0.00194	CcSEcCtD
Famotidine—Decreased appetite—Pravastatin—atherosclerosis	0.000646	0.00193	CcSEcCtD
Famotidine—Pain—Niacin—atherosclerosis	0.000646	0.00193	CcSEcCtD
Famotidine—Fatigue—Pravastatin—atherosclerosis	0.000641	0.00192	CcSEcCtD
Famotidine—Pain—Pravastatin—atherosclerosis	0.000636	0.0019	CcSEcCtD
Famotidine—Constipation—Pravastatin—atherosclerosis	0.000636	0.0019	CcSEcCtD
Famotidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000635	0.0019	CcSEcCtD
Famotidine—Asthenia—Lovastatin—atherosclerosis	0.000631	0.00189	CcSEcCtD
Famotidine—Pruritus—Lovastatin—atherosclerosis	0.000622	0.00186	CcSEcCtD
Famotidine—Asthenia—Ezetimibe—atherosclerosis	0.000619	0.00185	CcSEcCtD
Famotidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000617	0.00185	CcSEcCtD
Famotidine—Nausea—Rosuvastatin—atherosclerosis	0.000616	0.00184	CcSEcCtD
Famotidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000613	0.00183	CcSEcCtD
Famotidine—Pruritus—Ezetimibe—atherosclerosis	0.00061	0.00183	CcSEcCtD
Famotidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000608	0.00182	CcSEcCtD
Famotidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000606	0.00181	CcSEcCtD
Famotidine—Diarrhoea—Lovastatin—atherosclerosis	0.000602	0.0018	CcSEcCtD
Famotidine—Urticaria—Niacin—atherosclerosis	0.0006	0.00179	CcSEcCtD
Famotidine—Abdominal pain—Niacin—atherosclerosis	0.000597	0.00179	CcSEcCtD
Famotidine—Body temperature increased—Niacin—atherosclerosis	0.000597	0.00179	CcSEcCtD
Famotidine—Urticaria—Pravastatin—atherosclerosis	0.000591	0.00177	CcSEcCtD
Famotidine—Asthenia—Simvastatin—atherosclerosis	0.00059	0.00177	CcSEcCtD
Famotidine—Diarrhoea—Ezetimibe—atherosclerosis	0.00059	0.00177	CcSEcCtD
Famotidine—Abdominal pain—Pravastatin—atherosclerosis	0.000588	0.00176	CcSEcCtD
Famotidine—Body temperature increased—Pravastatin—atherosclerosis	0.000588	0.00176	CcSEcCtD
Famotidine—Pruritus—Simvastatin—atherosclerosis	0.000582	0.00174	CcSEcCtD
Famotidine—Dizziness—Lovastatin—atherosclerosis	0.000581	0.00174	CcSEcCtD
Famotidine—Dizziness—Ezetimibe—atherosclerosis	0.00057	0.00171	CcSEcCtD
Famotidine—Diarrhoea—Simvastatin—atherosclerosis	0.000563	0.00168	CcSEcCtD
Famotidine—Vomiting—Lovastatin—atherosclerosis	0.000559	0.00167	CcSEcCtD
Famotidine—Hypersensitivity—Niacin—atherosclerosis	0.000556	0.00166	CcSEcCtD
Famotidine—Rash—Lovastatin—atherosclerosis	0.000554	0.00166	CcSEcCtD
Famotidine—Dermatitis—Lovastatin—atherosclerosis	0.000554	0.00166	CcSEcCtD
Famotidine—Headache—Lovastatin—atherosclerosis	0.000551	0.00165	CcSEcCtD
Famotidine—Vomiting—Ezetimibe—atherosclerosis	0.000548	0.00164	CcSEcCtD
Famotidine—Hypersensitivity—Pravastatin—atherosclerosis	0.000548	0.00164	CcSEcCtD
Famotidine—Dizziness—Simvastatin—atherosclerosis	0.000544	0.00163	CcSEcCtD
Famotidine—Rash—Ezetimibe—atherosclerosis	0.000544	0.00163	CcSEcCtD
Famotidine—Dermatitis—Ezetimibe—atherosclerosis	0.000543	0.00163	CcSEcCtD
Famotidine—Asthenia—Niacin—atherosclerosis	0.000542	0.00162	CcSEcCtD
Famotidine—Headache—Ezetimibe—atherosclerosis	0.00054	0.00162	CcSEcCtD
Famotidine—Pruritus—Niacin—atherosclerosis	0.000534	0.0016	CcSEcCtD
Famotidine—Asthenia—Pravastatin—atherosclerosis	0.000533	0.0016	CcSEcCtD
Famotidine—Pruritus—Pravastatin—atherosclerosis	0.000526	0.00157	CcSEcCtD
Famotidine—Vomiting—Simvastatin—atherosclerosis	0.000523	0.00156	CcSEcCtD
Famotidine—Nausea—Lovastatin—atherosclerosis	0.000522	0.00156	CcSEcCtD
Famotidine—Rash—Simvastatin—atherosclerosis	0.000519	0.00155	CcSEcCtD
Famotidine—Dermatitis—Simvastatin—atherosclerosis	0.000518	0.00155	CcSEcCtD
Famotidine—Diarrhoea—Niacin—atherosclerosis	0.000517	0.00155	CcSEcCtD
Famotidine—Headache—Simvastatin—atherosclerosis	0.000515	0.00154	CcSEcCtD
Famotidine—Nausea—Ezetimibe—atherosclerosis	0.000512	0.00153	CcSEcCtD
Famotidine—Diarrhoea—Pravastatin—atherosclerosis	0.000509	0.00152	CcSEcCtD
Famotidine—Dizziness—Niacin—atherosclerosis	0.000499	0.00149	CcSEcCtD
Famotidine—Dizziness—Pravastatin—atherosclerosis	0.000492	0.00147	CcSEcCtD
Famotidine—Nausea—Simvastatin—atherosclerosis	0.000488	0.00146	CcSEcCtD
Famotidine—Vomiting—Niacin—atherosclerosis	0.00048	0.00144	CcSEcCtD
Famotidine—Rash—Niacin—atherosclerosis	0.000476	0.00142	CcSEcCtD
Famotidine—Dermatitis—Niacin—atherosclerosis	0.000476	0.00142	CcSEcCtD
Famotidine—Headache—Niacin—atherosclerosis	0.000473	0.00142	CcSEcCtD
Famotidine—Vomiting—Pravastatin—atherosclerosis	0.000473	0.00141	CcSEcCtD
Famotidine—Rash—Pravastatin—atherosclerosis	0.000469	0.0014	CcSEcCtD
Famotidine—Dermatitis—Pravastatin—atherosclerosis	0.000468	0.0014	CcSEcCtD
Famotidine—Headache—Pravastatin—atherosclerosis	0.000466	0.00139	CcSEcCtD
Famotidine—Nausea—Niacin—atherosclerosis	0.000449	0.00134	CcSEcCtD
Famotidine—Nausea—Pravastatin—atherosclerosis	0.000442	0.00132	CcSEcCtD
Famotidine—HRH2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000106	0.00209	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000106	0.00208	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRH1—atherosclerosis	0.000104	0.00203	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000104	0.00203	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CNR2—atherosclerosis	0.000101	0.00198	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	9.98e-05	0.00196	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	9.89e-05	0.00194	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	9.47e-05	0.00186	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	9.47e-05	0.00186	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PLAT—atherosclerosis	9.36e-05	0.00183	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.36e-05	0.00183	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LDLRAP1—atherosclerosis	9.25e-05	0.00181	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AGT—atherosclerosis	9.15e-05	0.00179	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLTP—atherosclerosis	8.69e-05	0.0017	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—ALB—atherosclerosis	8.68e-05	0.0017	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL3—atherosclerosis	8.67e-05	0.0017	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDNRA—atherosclerosis	8.64e-05	0.00169	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCR2—atherosclerosis	8.64e-05	0.00169	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—PRKCG—atherosclerosis	8.45e-05	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—F2—atherosclerosis	8.45e-05	0.00166	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GHRL—atherosclerosis	8.42e-05	0.00165	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA4—atherosclerosis	8.14e-05	0.0016	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PLG—atherosclerosis	7.96e-05	0.00156	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCR2—atherosclerosis	7.84e-05	0.00154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDNRA—atherosclerosis	7.84e-05	0.00154	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	7.82e-05	0.00153	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GHRL—atherosclerosis	7.65e-05	0.0015	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG8—atherosclerosis	7.54e-05	0.00148	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LTA4H—atherosclerosis	7.54e-05	0.00148	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCL2—atherosclerosis	7.53e-05	0.00148	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL4—atherosclerosis	7.5e-05	0.00147	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	7.49e-05	0.00147	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CETP—atherosclerosis	7.39e-05	0.00145	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—KNG1—atherosclerosis	7.39e-05	0.00145	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGTR1—atherosclerosis	7.35e-05	0.00144	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.35e-05	0.00144	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTM1—atherosclerosis	7.3e-05	0.00143	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—atherosclerosis	7.2e-05	0.00141	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	7.04e-05	0.00138	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	7.04e-05	0.00138	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOB—atherosclerosis	7.04e-05	0.00138	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA2—atherosclerosis	7.01e-05	0.00137	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	6.91e-05	0.00135	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	6.79e-05	0.00133	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KNG1—atherosclerosis	6.71e-05	0.00132	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—UTS2—atherosclerosis	6.69e-05	0.00131	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGTR1—atherosclerosis	6.67e-05	0.00131	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.51e-05	0.00128	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CX3CR1—atherosclerosis	6.41e-05	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASR—atherosclerosis	6.41e-05	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CX3CL1—atherosclerosis	6.29e-05	0.00123	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	6.28e-05	0.00123	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDN1—atherosclerosis	6.23e-05	0.00122	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCL5—atherosclerosis	6.18e-05	0.00121	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.04e-05	0.00118	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CNR2—atherosclerosis	5.96e-05	0.00117	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG1—atherosclerosis	5.96e-05	0.00117	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL8—atherosclerosis	5.96e-05	0.00117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	5.95e-05	0.00117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	5.95e-05	0.00117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	5.95e-05	0.00117	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	5.95e-05	0.00117	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MMP3—atherosclerosis	5.95e-05	0.00117	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.93e-05	0.00116	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.88e-05	0.00115	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PRKCG—atherosclerosis	5.87e-05	0.00115	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.68e-05	0.00111	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDN1—atherosclerosis	5.66e-05	0.00111	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL5—atherosclerosis	5.61e-05	0.0011	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FABP4—atherosclerosis	5.6e-05	0.0011	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LCAT—atherosclerosis	5.6e-05	0.0011	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.57e-05	0.00109	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PLG—atherosclerosis	5.54e-05	0.00109	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA4—atherosclerosis	5.5e-05	0.00108	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.44e-05	0.00107	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP7A1—atherosclerosis	5.4e-05	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PRKCG—atherosclerosis	5.33e-05	0.00105	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VWF—atherosclerosis	5.31e-05	0.00104	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOC3—atherosclerosis	5.28e-05	0.00103	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LDLR—atherosclerosis	5.25e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.24e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	5.18e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGT—atherosclerosis	5.17e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL3—atherosclerosis	5.12e-05	0.001	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.11e-05	0.001	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.06e-05	0.000992	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP27A1—atherosclerosis	4.99e-05	0.000979	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NCF1—atherosclerosis	4.91e-05	0.000962	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.9e-05	0.00096	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLTP—atherosclerosis	4.87e-05	0.000954	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—F2—atherosclerosis	4.78e-05	0.000936	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	4.73e-05	0.000928	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	4.73e-05	0.000928	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALOX15—atherosclerosis	4.73e-05	0.000928	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA2—atherosclerosis	4.73e-05	0.000928	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGT—atherosclerosis	4.69e-05	0.00092	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG5—atherosclerosis	4.68e-05	0.000917	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCR2—atherosclerosis	4.63e-05	0.000908	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDNRA—atherosclerosis	4.63e-05	0.000908	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CYBA—atherosclerosis	4.61e-05	0.000904	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CG—atherosclerosis	4.57e-05	0.000896	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PARP1—atherosclerosis	4.52e-05	0.000885	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GHRL—atherosclerosis	4.52e-05	0.000885	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLAT—atherosclerosis	4.52e-05	0.000885	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPA—atherosclerosis	4.52e-05	0.000885	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.51e-05	0.000884	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.48e-05	0.000878	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.45e-05	0.000873	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	4.41e-05	0.000865	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—BGN—atherosclerosis	4.37e-05	0.000857	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.35e-05	0.000853	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—F2—atherosclerosis	4.34e-05	0.00085	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA5—atherosclerosis	4.33e-05	0.000849	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG8—atherosclerosis	4.22e-05	0.000827	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LTA4H—atherosclerosis	4.22e-05	0.000827	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	4.17e-05	0.000817	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.17e-05	0.000817	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CG—atherosclerosis	4.15e-05	0.000814	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.13e-05	0.000809	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALOX5—atherosclerosis	4.03e-05	0.000789	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KNG1—atherosclerosis	3.96e-05	0.000777	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGTR1—atherosclerosis	3.94e-05	0.000772	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.93e-05	0.000771	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.87e-05	0.000759	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—atherosclerosis	3.87e-05	0.000758	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLG—atherosclerosis	3.84e-05	0.000753	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SOCS3—atherosclerosis	3.64e-05	0.000713	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NAMPT—atherosclerosis	3.61e-05	0.000708	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LIPC—atherosclerosis	3.59e-05	0.000703	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOC3—atherosclerosis	3.57e-05	0.000699	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LDLR—atherosclerosis	3.54e-05	0.000695	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP3—atherosclerosis	3.51e-05	0.000689	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.51e-05	0.000687	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—atherosclerosis	3.5e-05	0.000685	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CETP—atherosclerosis	3.46e-05	0.000679	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOB—atherosclerosis	3.39e-05	0.000665	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—atherosclerosis	3.37e-05	0.00066	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDN1—atherosclerosis	3.34e-05	0.000655	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG1—atherosclerosis	3.34e-05	0.000654	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL5—atherosclerosis	3.31e-05	0.00065	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SCARB1—atherosclerosis	3.31e-05	0.00065	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LPL—atherosclerosis	3.24e-05	0.000635	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PRKCG—atherosclerosis	3.15e-05	0.000618	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FABP4—atherosclerosis	3.14e-05	0.000615	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LCAT—atherosclerosis	3.14e-05	0.000615	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMGCR—atherosclerosis	3.13e-05	0.000614	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA4—atherosclerosis	3.08e-05	0.000603	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SPP1—atherosclerosis	3.07e-05	0.000602	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.07e-05	0.000602	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—atherosclerosis	3.06e-05	0.000599	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP7A1—atherosclerosis	3.02e-05	0.000593	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.88e-05	0.000565	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDGFB—atherosclerosis	2.84e-05	0.000557	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.8e-05	0.000548	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCA1—atherosclerosis	2.79e-05	0.000547	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—atherosclerosis	2.77e-05	0.000544	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.75e-05	0.000539	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—atherosclerosis	2.72e-05	0.000533	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—atherosclerosis	2.72e-05	0.000533	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—atherosclerosis	2.69e-05	0.000528	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—atherosclerosis	2.69e-05	0.000526	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.68e-05	0.000526	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA2—atherosclerosis	2.65e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.65e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.65e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.65e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.62e-05	0.000513	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.61e-05	0.000513	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ESR1—atherosclerosis	2.59e-05	0.000508	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—F2—atherosclerosis	2.56e-05	0.000502	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPA—atherosclerosis	2.53e-05	0.000496	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—atherosclerosis	2.45e-05	0.000481	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—BGN—atherosclerosis	2.45e-05	0.00048	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.43e-05	0.000476	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA5—atherosclerosis	2.42e-05	0.000475	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—atherosclerosis	2.39e-05	0.000469	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.35e-05	0.000461	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK3—atherosclerosis	2.35e-05	0.00046	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.33e-05	0.000457	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—atherosclerosis	2.32e-05	0.000455	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.31e-05	0.000452	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOB—atherosclerosis	2.29e-05	0.000449	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.29e-05	0.000448	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—atherosclerosis	2.28e-05	0.000448	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.28e-05	0.000447	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.25e-05	0.000442	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—atherosclerosis	2.25e-05	0.00044	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.23e-05	0.000437	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPL—atherosclerosis	2.19e-05	0.000429	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—atherosclerosis	2.14e-05	0.000419	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—atherosclerosis	2.13e-05	0.000418	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.08e-05	0.000408	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD36—atherosclerosis	2.08e-05	0.000408	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—atherosclerosis	2.04e-05	0.000399	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.02e-05	0.000396	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.01e-05	0.000394	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LIPC—atherosclerosis	2.01e-05	0.000394	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOC3—atherosclerosis	2e-05	0.000391	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.98e-05	0.000389	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.97e-05	0.000386	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CETP—atherosclerosis	1.94e-05	0.00038	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARA—atherosclerosis	1.93e-05	0.000379	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—atherosclerosis	1.87e-05	0.000367	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.86e-05	0.000364	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—atherosclerosis	1.84e-05	0.00036	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—atherosclerosis	1.82e-05	0.000356	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—atherosclerosis	1.81e-05	0.000356	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.81e-05	0.000354	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—atherosclerosis	1.81e-05	0.000354	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.75e-05	0.000343	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—atherosclerosis	1.74e-05	0.000342	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—atherosclerosis	1.72e-05	0.000337	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.66e-05	0.000325	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—atherosclerosis	1.63e-05	0.00032	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NFKB1—atherosclerosis	1.62e-05	0.000317	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—atherosclerosis	1.6e-05	0.000313	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—atherosclerosis	1.59e-05	0.000311	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—atherosclerosis	1.58e-05	0.00031	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.58e-05	0.00031	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—atherosclerosis	1.57e-05	0.000307	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.56e-05	0.000306	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—atherosclerosis	1.47e-05	0.000287	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—atherosclerosis	1.45e-05	0.000285	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—atherosclerosis	1.44e-05	0.000282	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK3—atherosclerosis	1.39e-05	0.000272	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—atherosclerosis	1.37e-05	0.00027	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—atherosclerosis	1.35e-05	0.000264	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.34e-05	0.000263	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOB—atherosclerosis	1.28e-05	0.000252	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.26e-05	0.000247	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.25e-05	0.000245	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPL—atherosclerosis	1.23e-05	0.00024	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.2e-05	0.000234	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD36—atherosclerosis	1.16e-05	0.000228	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.1e-05	0.000216	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARA—atherosclerosis	1.08e-05	0.000212	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—atherosclerosis	1.05e-05	0.000206	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—atherosclerosis	1.03e-05	0.000201	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—atherosclerosis	1.02e-05	0.0002	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—atherosclerosis	1.02e-05	0.000199	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—atherosclerosis	1.01e-05	0.000199	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—atherosclerosis	9.36e-06	0.000183	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	9.27e-06	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—atherosclerosis	8.95e-06	0.000175	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—atherosclerosis	8.78e-06	0.000172	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—atherosclerosis	8.04e-06	0.000158	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—atherosclerosis	7.7e-06	0.000151	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—atherosclerosis	7.04e-06	0.000138	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—atherosclerosis	6.32e-06	0.000124	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—atherosclerosis	3.54e-06	6.93e-05	CbGpPWpGaD
